NASALswab. This is currently the only COVID-19 test we perform that does NOT require nasopharyngeal specimen collection. Use Puritan Foam Tipped Swab. These are available from the lab and will be kept in a designated area on each unit.
Specimen Preparation
Once collected, place the swab with specimen back into the original wrapper it came in. The wrapper will serve as specimen container for transport
Place Cerner label on the outside of the swab wrapper (only)
Document the TIME of collection on the Cerner label, to the right of the barcode
Place the labeled wrapper with the specimen in a biohazard bag, and make sure it is well sealed (since it is a dry specimen, only 1 biohazard bag is needed)
Sample must be hand delivered to lab within 1 hour (NEVER send via the tube system)
Hospital laboratory or Ambulatory Surgery Center as appropriate
Turn around time is usually 1-2 hours
Ordering Recommendations
Patients who are symptomatic and/or meet criteria for testing
L&D
Elective surgery (scheduled within 24 hours)
Methodology
Abbott Rapid Test System. This assay is based on isothermal nucleic acid amplification and targets a unique region of the RdRp segment of the SARS-CoV-2 virus
This assay is approved by the FDA as EUA (Emergency Use Authorization)
Synonyms
Coronavirus
SARS-CoV-2
Reference Interval
Negative
Interpretive Data
This test is for the detection of SARS-CoV-2 Coronavirus that causes the respiratory disease COVID-19.
A Positive result indicates that RNA from SARS-CoV-2 (formerly 2019-nCoV) was detected, and that the patient is considered infected with the virus and presumed to be contagious.
A Negative test result indicates that SARS-CoV-2 RNA was not detected. Negative results should be interpreted in combination with clinical observations and patient history.
An Invalid result indicates an inadequate specimen or incomplete detection of targets. Specimen recollection is required.
The test was performed with a rapid CLIA-waived molecular assay with FDA Emergency Use Authorization (EUA), utilizing isothermal amplification of SARS-CoV-2 genomic sequences. The test was verified and conducted within the BayCare Health System Laboratories.
Collection
Collect
NASALswab. This is currently the only COVID-19 test we perform that does NOT require nasopharyngeal specimen collection. Use Puritan Foam Tipped Swab. These are available from the lab and will be kept in a designated area on each unit.
Specimen Preparation
Once collected, place the swab with specimen back into the original wrapper it came in. The wrapper will serve as specimen container for transport
Place Cerner label on the outside of the swab wrapper (only)
Document the TIME of collection on the Cerner label, to the right of the barcode
Place the labeled wrapper with the specimen in a biohazard bag, and make sure it is well sealed (since it is a dry specimen, only 1 biohazard bag is needed)
Sample must be hand delivered to lab within 1 hour (NEVER send via the tube system)
Hospital laboratory or Ambulatory Surgery Center as appropriate
Turn around time is usually 1-2 hours
Ordering Recommendations
Patients who are symptomatic and/or meet criteria for testing
L&D
Elective surgery (scheduled within 24 hours)
Methodology
Abbott Rapid Test System. This assay is based on isothermal nucleic acid amplification and targets a unique region of the RdRp segment of the SARS-CoV-2 virus
This assay is approved by the FDA as EUA (Emergency Use Authorization)
Synonyms
Coronavirus
SARS-CoV-2
Result Interpretation
Reference Interval
Negative
Interpretive Data
This test is for the detection of SARS-CoV-2 Coronavirus that causes the respiratory disease COVID-19.
A Positive result indicates that RNA from SARS-CoV-2 (formerly 2019-nCoV) was detected, and that the patient is considered infected with the virus and presumed to be contagious.
A Negative test result indicates that SARS-CoV-2 RNA was not detected. Negative results should be interpreted in combination with clinical observations and patient history.
An Invalid result indicates an inadequate specimen or incomplete detection of targets. Specimen recollection is required.
The test was performed with a rapid CLIA-waived molecular assay with FDA Emergency Use Authorization (EUA), utilizing isothermal amplification of SARS-CoV-2 genomic sequences. The test was verified and conducted within the BayCare Health System Laboratories.
